C12N 2760/16261
Methods of inactivation or attenuation
C12N2760/16261 (Methods of inactivation or attenuation) appears on 64 US grants and 88 published applications in this corpus.
Search patents in C12N- Granted patents
- 64
- Published applications
- 88
- Assignees
- 35
- Inventors
- 72
- Latest grant
- 7 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 2 | 0 |
| 2004 | 0 | 3 |
| 2005 | 2 | 5 |
| 2006 | 0 | 4 |
| 2007 | 2 | 2 |
| 2008 | 3 | 3 |
| 2009 | 5 | 9 |
| 2010 | 1 | 5 |
| 2011 | 6 | 4 |
| 2012 | 6 | 10 |
| 2013 | 6 | 4 |
| 2014 | 9 | 6 |
| 2015 | 1 | 2 |
| 2016 | 5 | 8 |
| 2017 | 0 | 1 |
| 2018 | 3 | 2 |
| 2019 | 1 | 2 |
| 2020 | 1 | 4 |
| 2021 | 2 | 0 |
| 2022 | 2 | 5 |
| 2023 | 0 | 3 |
| 2024 | 3 | 2 |
| 2025 | 2 | 2 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compositions and methods for protecting against airborne pathogens and irritants7 Apr 2026US 12,594,285 B2Applied Biological Laboratories, Inc.
- Compositions and methods for protecting against airborne pathogens and irritants21 Oct 2025US 12,447,166 B2Applied Biological Laboratories, Inc.
- Influenza b virus mutants and uses therefor19 Aug 2025US 12,390,519 B2FluGen, Inc.
- Live attenuated influenza B virus compositions methods of making and using thereof3 Dec 2024US 12,156,910 B2Versitech Limited
- Engineered influenza antigenic polypeptides and immunogenic compositions thereof16 Jul 2024US 12,037,364 B2Sanofi Pasteur Limited
- Influenza b virus mutants and uses therefor10 Sep 2026US 2026/0263586 A1FluGen, Inc.
- Multipurpose Compositions for Collecting and Transporting Biological Material14 Aug 2025US 2025/0257330 A1Longhorn Vaccines and Diagnostics, LLC
- Influenza virus mutants and uses therefor20 Mar 2025US 2025/0090649 A1FluGen, Inc.
- Influenza vaccine16 May 2024US 2024/0156943 A1Denka Company Limited
- Influenza b virus mutants and uses therefor21 Mar 2024US 2024/0091337 A1FluGen, Inc.
Most cited
By later US patents
- DNA transfection system for the generation of infectious influenza virus91US 6,951,754 B2St. Jude Children?S Research Hospital · 2005
- Influenza hemagglutinin and neuraminidase variants71US 7,566,458 B2MedImmune, LLC · 2009
- Signal for packaging of influenza virus vectors47US 7,226,774 B2Wisconsin Alumni Research Foundation · 2007
- DNA transfection system for the generation of infectious influenza virus45US 7,312,064 B2St. Jude Children's Research Hosptal · 2007
- Recombinant influenza vectors with tandem transcription units41US 7,968,101 B2Wisconsin Alumni Research Foundation · 2011